Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares pursuant to ESOP-2017 Scheme21-06-2022
21-06-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING16-06-2022
Eris Lifesciences Ltd - 540596 - Board Meeting Outcome for OUTCOME OF THE BOARD MEETING
In accordance with the provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we hereby inform you that the Board of Directors of the Company at their meeting held on 15th June, 2022 has, inter alia, transacted the following business: ? Mr. Prashant Gupta's term as an independent director of the company is completing on 29 April 2023. The Board has, subject to approval of the members, approved his reappointment as an independent director for a further period of 5 years starting from 30 April 2023. ? Convening of Annual General Meeting (AGM) of the Members of the Company on Thursday, September 01, 2022.15-06-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING13-06-2022
Eris Lifesciences Ltd - 540596 - DISCLOSURES OF RELATED PARTY TRANSACTIONS UNDER REGULATION 23(9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015, AS AMENDED ('SEBI LISTING REGULATIONS')
Pursuant to Regulation 23(9) of the SEBI Listing Regulations, please find enclosed herewith disclosures of related party transactions on consolidated basis in the revised format, as prescribed by SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22 November 2021, for the half-year ended commencing from 1 October 2021 to 31 March 2022. Kindly take note the same.30-05-2022
Eris Lifesciences Ltd - 540596 - Compliances-Reg.24(A)-Annual Secretarial Compliance
COMPLIANCE UNDER REGULATION 24(A) OF SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 201528-05-2022
Eris Lifesciences Ltd - 540596 - CORPORATE PRESENTATION
Dear Sir/Madam, Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached corporate presentation made by the Company.18-05-2022
Eris Lifesciences Ltd - 540596 - UPDATE ON ACQUISTION OF OAKNET HEALTHCARE PRIVATE LIMITED
We refer to our earlier intimation dated 04th May, 2022, for acquisition of Oaknet Healthcare Private Limited. We now wish to inform that the transaction has achieved closure. This is for you information and record.17-05-2022
Buy Eris Lifesciences; target of Rs 870: Motilal Oswal
Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated May 16, 2022.17-05-2022
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
TRANSCRIPT OF ANALYST AND INVESTOR CALL10-05-2022